European Medicines Agency (EMA) — News Health Press Releases — RSS Feed & Live Monitoring
PPN World indexes European Medicines Agency (EMA) — News press releases and archives each one it distributes. This wire has been quiet since November 13, 2026 — its 70 indexed releases remain searchable, and an alert will tell you the moment it publishes again.
Free daily email
What breaks tomorrow
Tomorrow’s key world events from the PPN World agenda (central banks, data releases, elections, summits), in your inbox every evening at 17:00 UTC.
One email a day. No account needed. Unsubscribe in one click.
About this feed
European Medicines Agency (EMA) — News is one of the 1,400+ press-release feeds PPN World monitors around the clock — an English-language wire focused on Health, filed among our international wires. Every release is deduplicated, geotagged, and enriched with an AI summary, and you can attach saved-search alerts to any keyword it publishes. The most recent release in our index was published on November 13, 2026; the wire has been quiet since.
Track European Medicines Agency (EMA) — News in real time in PPN World
Every European Medicines Agency (EMA) — News release lands in the cockpit seconds after it publishes — deduplicated, classified, with saved-search alerts and AI summaries, alongside 1,400+ other wires.
Create free account →European Medicines Agency (EMA) — News press releases — archive
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 20269 d ago
Seven new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended seven medicines for approval at its November 2026 meeting.The committee…, CHMP statistics Key figures fro…
- Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 November 202615 d ago
CVMP opinions on veterinary medicinal products Further to the re-examination of the opinion adopted by the Committee during its June 2026 meeting, the Committee adopted a…
- PRAC starts review of depression and anxiety medicine Deanxit (flupentixol/melitracen)22 d ago
EMA’s safety committee (PRAC) has started a review of Deanxit, a fixed-dose combination medicine for treating depression and anxiety, following reports of serious neurological…
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26 - 29 October 202623 d ago
PRAC starts review of depression and anxiety medicine Deanxit (flupentixol/melitracen)PRAC has started a review of Deanxit, a fixed-dose combination medicine for treating…, Agenda Agenda of the PRAC m…
- EMA closed on All Souls' Day, 2 November23 d ago
EMA’s office is closed on Monday 2 November, to mark All Souls' Day. The office reopens at 08:30 on Tuesday 3 November.The product emergency hotline is available outside…
- AMA and EMA issue joint guidance on Ebola vaccine development30 d ago
EMA’s Emergency Task Force (ETF) and the African Medicines Agency (AMA) have published a joint position paper to support the timely start of clinical trials for potential…
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 202637 d ago
Six new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended six medicines for approval at its October 2026 meeting.Rasonque (daraxonrasib)…, CHMP statistics Key figure…
- EMA recommends authorisation of Rasonque for metastatic pancreatic cancer37 d ago
EMA’s human medicines committee (CHMP) has recommended granting a marketing authorisation in the European Union for Rasonque (daraxonrasib), an oral treatment for adults with…
- Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 October 202643 d ago
CVMP opinions on veterinary medicinal productsThe Committee adopted a positive opinion, in exceptional circumstances, for a marketing authorisation for Bovilis Lumpyvax (lumpy…
- Clinical trial applications advice pilot becomes permanent44 d ago
The Accelerating Clinical Trials in the EU (ACT EU) advice pilot, which helps sponsors prepare clinical trial applications, will become a permanent initiative from January 2027.…
- Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 September - 1 October51 d ago
At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities to manage the safety of medicines, including the assessment of safety…, Agenda Agenda of the PRAC…
- Advice on ‘end-of-year’ submission dates for type I variations in 202651 d ago
Marketing authorisation holders wishing to receive an outcome in 2026 should submit type IA annual updates, individual type IA and type IAIN variations, and super-groupings…
The newest releases on this wire stream live for PPN World members.
Frequently asked questions
How do I follow European Medicines Agency (EMA) — News press releases in real time?+
How often are European Medicines Agency (EMA) — News press releases picked up?+
What kind of press releases does European Medicines Agency (EMA) — News publish?+
Related feeds
- U.S. FDA
- UK Department of Health & Social Care
- NSW Minister for Health Media Releases
- U.S. CDC
- Inserm — Salle de presse
- Anses — Sécurité sanitaire (France)
- Ministério da Saúde (Brasil)
- Ministry of Health, Labour and Welfare Japan (MHLW)
- U.S. Department of Veterans Affairs (VA News)
- Statistics Canada — The Daily: Health